Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06080308
Other study ID # TJ-IRB20230940
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 10, 2023
Est. completion date September 30, 2024

Study information

Verified date April 2024
Source Tongji Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Searching for new targets for the diagnosis and treatment of liver ischemia-reperfusion injury.


Description:

Through the analysis of serological data during liver resection elective surgery with hepatic pedicle occlusion and reperfusion, as well as the analysis of patient-related data, we aim to identify key target points that affect reperfusion injury and explore their underlying mechanisms.


Recruitment information / eligibility

Status Recruiting
Enrollment 270
Est. completion date September 30, 2024
Est. primary completion date December 20, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Willingness to participate in the study and has signed an informed consent form. 2) Age = 18 years and = 70 years. 3) ASA classification = III. 4) Criteria for liver ischemia-reperfusion injury patients: patients undergoing elective liver resection surgery with hepatic pedicle occlusion and reperfusion during the procedure. Exclusion Criteria: 1) Patients with adverse events during surgery. 2) Patients in the end stage of disease with liver failure. 3) Liver tumor metastasis with concomitant severe heart failure or chronic renal insufficiency, etc. 4) Deemed unsuitable for participation in the study based on the judgment of the researchers. -

Study Design


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
China Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Qin Zhang

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of hospital stay Length of hospital stay 7days
See also
  Status Clinical Trial Phase
Completed NCT06244550 - Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors N/A
Completed NCT01089426 - Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury N/A
Recruiting NCT05229328 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
Recruiting NCT05155358 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
Terminated NCT04004884 - Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)
Recruiting NCT01802996 - Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury Phase 4
Active, not recruiting NCT05882214 - Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink N/A
Completed NCT04934384 - The Role of Prehospital eFAST in Accelerating Time to Diagnostics or Definitive Treatment in the Emergency Department
Recruiting NCT03039062 - Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy N/A
Completed NCT00694499 - Non-Operative Management of High Grade Blunt Hepatic Injury: Clinical Complications and the Role of Collateral Damage N/A
Recruiting NCT04937868 - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Completed NCT06249646 - Contained Hepatic Vascular Injuries Following Liver Trauma
Recruiting NCT06402981 - A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients
Terminated NCT02915081 - Blue Light Therapy for Liver Surgery N/A
Completed NCT03281265 - A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China N/A
Completed NCT03667157 - Liver Function After Intravenous Methylprednisolone Administration Phase 4
Completed NCT04257240 - Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury
Not yet recruiting NCT02808299 - Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection N/A
Not yet recruiting NCT06258525 - SAMe in Prevention of Oxaliplatin-associated Liver Injury Phase 2
Active, not recruiting NCT06298318 - Metabolic Changes in Healthy Subjects With Acute Binge Drink N/A